Why regulatory timelines feel less predictable than ever (even when your device is ready) 

Many medical device companies assume that once technical documentation is complete, testing has been finalized, and the device performs as intended, regulatory timelines become relatively predictable. Yet effective regulatory strategy for medical devices typically requires organizations to look beyond submission readiness alone.  Increasingly, that assumption is being tested.  Across Europe and other major markets, regulatory […]